Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by toinv261on Aug 08, 2016 6:53pm
101 Views
Post# 25120952

RE:RE:RE:RE:FTHX HEARTLAND /MY SENTIMENTS EXCATLY

RE:RE:RE:RE:FTHX HEARTLAND /MY SENTIMENTS EXCATLYHi GV.

I don't disagree with you but there are many things Don is not doing.

It will be scientific  results that will drive the stock. A NASDAQ listing would give credibility and breadth of market. A FDA approval would help but I am not concerned about that. Brilliant scientists are spread throughout the world and the EU is far more advanced than the USA and that is where BETonMACE is happening..

We know the steering committee for BETonMACE are highly regarded international scientists and therefore things are in good hands.

However, the business and communications sides of things leave a lot to be desired.

So I say, we should not be easy on Don. He should address many of the questions submitted by Agoracom.

Best regards
Toinv
Bullboard Posts